Zobrazeno 1 - 10
of 80
pro vyhledávání: ''
Publikováno v:
JAMA Dermatol
IMPORTANCE: Although several single-center studies have estimated that granuloma annulare may account for approximately 0.1% to 0.4% of new patients presenting to dermatologists, large-scale population-based studies estimating the prevalence and inci
Publikováno v:
JAMA Dermatology. 157:708
Importance Although limited effective and affordable treatment options exist for hidradenitis suppurativa, recent studies describe the effectiveness of a medical therapy, infliximab, for the treatment of hidradenitis suppurativa. Cost-saving biosimil
Autor:
Luis Puig, Jose Bernabeu-Wittel, Ignasi Gich, Monica Rios, María Teresa Montserrat-García, Eulalia Baselga, Fania Zamantta Muñoz-Garza, Esther Roé-Crespo
Publikováno v:
JAMA Dermatol
JAMA DERMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
JAMA Dermatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
JAMA DERMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
JAMA Dermatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
IMPORTANCE: Treatment of infantile hemangioma (IH) with topical timolol in the first 2 months of life (early proliferative phase) may prevent further growth and the need for treatment with oral propranolol. To our knowledge, no studies have determine
Publikováno v:
JAMA Dermatol
Importance Topical calcineurin inhibitors (TCIs) are commonly used as second-line treatment for atopic dermatitis. In 2006, the US Food and Drug Administration issued a black box warning against TCI use, citing data from case reports and animal studi
Publikováno v:
JAMA Dermatol
This cohort study evaluates the association of etanercept treatment with outcomes of reactive infectious mucocutaneous eruption in hospitalized children and adolescents.
Autor:
Amit Maity, Alain H. Rook, Jennifer Villaseñor-Park, Carmela C. Vittorio, Kevin Zhang, Paul Haun, Sara A. Berg, Sara Samimi, Joanne Inverso, Daniel J. Lewis, Jaclyn Rosenthal, Christina A Del Guzzo, Ellen J. Kim, Maria Wysocka, Jessica E. Teague, Neha Jariwala, Bernice M. Benoit, Joseph S. Durgin, John P. Plastaras, Rachael A. Clark
Publikováno v:
JAMA Dermatol
Importance Sezary syndrome (SS) is an advanced form of cutaneous T-cell lymphoma with few long-term remissions observed. Objective To profile 3 patients with SS who have experienced long-term remission following the addition of low-dose total skin el
Autor:
Mariluz van de L’Isle Arias, Juul M. P. A. van den Reek, Satish F K Lubeek, Marieke E.C. van Winden, Lara S. van der Schoot, Lieke J. van Vugt, Elke M G J de Jong, Peter C.M. van de Kerkhof
Publikováno v:
Jama Dermatology, 156, 1229-1239
Jama Dermatology, 156, 11, pp. 1229-1239
Jama Dermatology, 156, 11, pp. 1229-1239
Contains fulltext : 229411.pdf (Publisher’s version ) (Closed access) Importance: Treating older adults with psoriasis can be challenging owing to comorbidities, concomitant medication use, and consequent safety risks. Although many studies focus o
Publikováno v:
JAMA Dermatol
IMPORTANCE: Up to 90% of patients treated with an epidermal growth factor receptor inhibitor (EGFRi) experience cutaneous toxic effects that are negatively associated with quality of life and lead to treatment interruptions. The Skin Toxicity Evaluat
Publikováno v:
JAMA Dermatology. 156:1117
Importance Certain patient groups, such as solid organ transplant recipients (SOTRs), have a significantly increased risk of developing skin cancers. The chemotherapeutic drug capecitabine has been used off label as a chemopreventive modality to supp
Autor:
A. Lluch, Rocio Núñez-Torres, Belen Herraez, Julio César de la Torre-Montero, Begoña Bermejo, María Rodrigo-Faus, Anna González-Neira, Guillermo Pita, Miguel Martin, Lorena Peiró-Chova, María del Monte-Millán, Hugo Tejera-Pérez, Karen Pinilla, José A. García-Sáenz
Publikováno v:
JAMA Dermatology. 156:987
Importance Persistent chemotherapy-induced alopecia (pCIA) has been recently described in patients with breast cancer and in its most severe form occurs in up to 10% of these patients. Genetic risk factors associated with pCIA have not been adequatel